Systemic insights.

Faster healthy aging breakthroughs.

The NextGen scalable infrastructure to discover and develop healthy aging intervention – faster, at scale, and with confidence.

REQUEST A DEMO
EXPLORE THE PLATFORM
Telomir Pharmaceuticals logo: biotechnology company partnering with Nagi Bioscience in longevity and age-related disease research.
DTU Biosustain and Novo Nordisk Foundation logo: academic and research collaboration with Nagi Bioscience on healthy aging innovations.
Bayer CropScience logo: global agrochemical and agroscience company working with Nagi Bioscience on developmental and reprodutive toxicity DART.
Immunic Therapeutics logo: biotech company advancing immune and neurodegenerative therapeutics with support from Nagi Bioscience.
Harvard T.H. Chan School of Public Health logo: leading academic institution leveraging Nagi Bioscience platform SydLab One for aging biology research and metabolism and diet.
National and Kapodistrian University of Athens NKUA logo: Medical Faculty Palikaras research group advancing mechanisms of aging and neurodegeneration with support from Nagi Bioscience. Discovering combined interventions against Alzheimer's Disease.
ICMAB Institut de Ciència de Materials de Barcelona logo: microplastics ecotoxicology supported by Nagi Bioscience technology.
International Iberian Nanotechnology laboratory INL logo: safety toxicology testing of nanoparticles and how it affects models of neurodegeneration with the support from Nagi Bioscience technology.
Yeastup logo

SydLab™ ONE

Decision-ready, in vivo healthy aging insights in just 10 days

Biological age & healthspan modulation

Multi-tissue, system-level insights

Mechanism of action & target validation

De-risk compounds & prioritize candidates

In vivo multi-phenotypic and multi-omics insights – Seamlessly automated

Biological Core

C. elegans: the model of choice for fast and predictive aging screening.

  • Synchronize and confine C. elegans in the patented chips.
  • 16 independent conditions/chip, N=20-30/condition.
Explore The Model

Automation Engine

SydLab™ One: Benchtop platform for culture, treatment and imaging.

  • 4 chips running in parallel (=64 conditions, 1500+ organisms in total).
  • End-to-end automated, no prior C.elegans expertise required.
Explore The Platform

Multi-phenotypic insights

AI-powered image analysis quantifies +30 phenotypic biomarkers longitudinally.

  • Real-time image transfer, segmentation, and analysis on the Cloud.
  • Longitudinal quantification of phenotypic biomarkers.
Explore our Assays
outcome

Decision-ready data for follow-up screening steps, IP generation, and scientific publications.

Latest projects

Real science. Real impact.

what our customers say

With 15+ years of expertise in aging biology, we’ve supported 25+ teams worldwide.

Anna C. Möller

The Nagi healthspan approach allowed us to explore the potential benefits of beta-glucan consumption on biological ageing and physiology. It was especially interesting to test various concentrations of our product which resulted in a clear dose-dependent effect. The work forms our basis to explore the health benefits of beta-glucan further.

Anna C. Möller

CTO, YeastUp

Karl Alex Hedin, PhD

Their services revealed new insights and opened up exciting possibilities for exploring the potential of our strains in health applications related to healthy aging, helping us advance our research further.

Karl Alex Hedin, PhD

Post-Doctoral Researcher, DTU Biosustain, The Novo Nordisk Foundation Centre for Biosustainability

Erez Aminov

We are very pleased with Nagi Bioscience. Their innovative technology has been instrumental in allowing us to gather critical scientific data quickly, providing invaluable insights that significantly advance our research in longevity.

Erez Aminov

CEO, Telomir Pharmaceuticals, Inc.

Irina Fingerhut

Their high-throughput approach provided clear, quantifiable insights into the lifespan and functional effects of our lead combinations— critical data that helped de-risk and prioritize our therapeutic strategy.

Irina Fingerhut

Co-Founder/Sole Director, ElixIRA Pharma AG

Customer Spotlights

who we are

Pioneering the future of healthy aging discovery

Nagi Bioscience is a Swiss biotool company building the leading in vivo platform for the discovery and development of healthy aging interventions that improve the healthspan-lifespan gap.

We combine the power of C. elegans, microfluidics, automation and AI to deliver human-relevant insights faster, at scale.

Researcher at Nagi Bioscience lab accelerating drug discovery in aging biology with automated workflows.

our mission

To accelerate the discovery of effective and safe healthy aging interventions through predictive, system-level insights.

Nagi Bioscience research team combining Swiss-engineered precision with 15+ years of expertise in aging biology and drug discovery.

the newsletter for longevity innovators

The Age of Discovery — Briefings

Exclusive insights and case studies from longevity and healthy aging leaders delivered to your inbox.

Subscribe Now
Latest News

Stay informed. Stay ahead.

  • Rethinking aging through nutritional science: how biotechnology, AI, and whole-organism biology are redefining healthspan research.

    Rethinking Aging Through the Lens of Nutritional Science

    Rethinking aging through nutritional science: how biotechnology, AI, and whole-organism biology are redefining healthspan research.

    Read more

  • Aging Clocks: Measuring biological age and unlocking health insights

    Aging Clocks for discovery pipelines

    Aging Clocks are far more versatile than you may think. They can also be engines for discovery and validation in research and development.

    Read more

  • How C. elegans Data Supports Early Biotech R&D

    How C. elegans data supports early biotech R&D

    Discover 3 ways C. elegans models accelerate early-stage biotech R&D—from high-throughput screening to mechanistic validation and biomarker discovery.

    Read more

Accelerate breakthroughs.

Improve lifes.

Let’s Talk
Book a Demo